Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway
- PMID: 30442873
- PMCID: PMC6294623
- DOI: 10.1042/BSR20181501
Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway
Abstract
Osteosarcoma (OS) is the most common primary malignancy of skeleton with higher mortality rates amongst children and young adults worldwide, whereas effective and secure therapies have also been sought by researches with ongoing efforts. The purpose of the present study was to investigate the impact of N'-[(3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene] benzohydrazide (MDA19) on OS and explore its potential mechanism. Cell Counting Kit-8 (CCK8) and colony formation assay were employed to evaluate the potential effect of MDA19 on U2OS and MG-63 cells proliferation. Moreover, transwell migration and invasion assay were performed to assess the influence of MDA19 on U2OS and MG-63 cells migration and invasion. In addition, Annexin V-FITC/propidium iodide (Annexin V-FITC/PI) staining and flow cytometry were used to examine apoptotic ratio of the U2OS and MG-63 cells. Meanwhile, Western blot analysis was applied to explore change of relevant mechanism proteins in OS cells treated with MDA19. Our study showed that MDA19 had anti-proliferative activity of OS cells in a dose- and time-dependent manner, simultaneously, inhibition of colony formation was also observed in U2OS and MG-63 cells after incubation of MDA19. Besides, MDA19 could significantly inhibit the number of migrated and invaded OS cells and markedly increase the OS cells apoptosis rate. Mechanistically, we detected detectable reductions in apoptosis related proteins, epithelial-mesenchymal transition (EMT)-related proteins and activity of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling in U2OS and MG-63 cells exposure to MDA19. Overall, the current study indicates in vitro anti-proliferative, anti-metastatic, and pro-apoptotic potential of MDA19 in U2OS and MG-63 cells. Our findings propose a clue for further studies with this compound in preclinical and clinical treatment for OS.
Keywords: EMT; MDA19; Osteosarcoma; PI3K/Akt/mTOR signaling.
© 2018 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures





Similar articles
-
Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.Histol Histopathol. 2020 Dec;35(12):1511-1520. doi: 10.14670/HH-18-299. Epub 2020 Dec 29. Histol Histopathol. 2020. PMID: 33372687
-
Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.Med Sci Monit. 2018 Sep 5;24:6178-6186. doi: 10.12659/MSM.910201. Med Sci Monit. 2018. PMID: 30182951 Free PMC article.
-
Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):105-112. doi: 10.26355/eurrev_201901_16754. Eur Rev Med Pharmacol Sci. 2019. PMID: 30657552
-
PI3K/Akt signaling in osteosarcoma.Clin Chim Acta. 2015 Apr 15;444:182-92. doi: 10.1016/j.cca.2014.12.041. Epub 2015 Feb 19. Clin Chim Acta. 2015. PMID: 25704303 Review.
-
mTOR: An attractive therapeutic target for osteosarcoma?Oncotarget. 2016 Aug 2;7(31):50805-50813. doi: 10.18632/oncotarget.9305. Oncotarget. 2016. PMID: 27177330 Free PMC article. Review.
Cited by
-
LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.Biosci Rep. 2019 Apr 30;39(4):BSR20190447. doi: 10.1042/BSR20190447. Print 2019 Apr 30. Biosci Rep. 2019. PMID: 30944201 Free PMC article.
-
The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair.J Bone Oncol. 2020 Apr 19;23:100290. doi: 10.1016/j.jbo.2020.100290. eCollection 2020 Aug. J Bone Oncol. 2020. PMID: 32368441 Free PMC article.
-
Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway.Genes Dis. 2022 Aug 6;10(5):2125-2136. doi: 10.1016/j.gendis.2022.06.010. eCollection 2023 Sep. Genes Dis. 2022. PMID: 37492722 Free PMC article.
-
Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer.Front Oncol. 2022 Dec 14;12:1034750. doi: 10.3389/fonc.2022.1034750. eCollection 2022. Front Oncol. 2022. PMID: 36591458 Free PMC article.
-
MFNG is an independent prognostic marker for osteosarcoma.Eur J Med Res. 2023 Jul 26;28(1):256. doi: 10.1186/s40001-023-01139-x. Eur J Med Res. 2023. PMID: 37496053 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous